Many recent studies support that the aberrant expression of TG2 can produce oncogenic signaling that promotes an aggressive phenotype in cancer cells [15]–[20], [44] and thus may represent the missing link between inflammation and cancer progression. This evidence concerns the gene TGM2 and cancer.